Physician profile
Mary E Coleman
NPI 1609961358
$683.12
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.64 · 2022: $466 · 2023: $132 · 2024: $45.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $135.92 | 2023-2024 | Apretude |
| Novo Nordisk INC | $102.90 | 2022 | |
| Astellas Pharma US INC | $66.75 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $54.41 | 2022-2023 | Farxiga |
| Hologic Sales and Service, LLC | $38.94 | 2019-2022 | |
| Edwards Lifesciences Corporation | $30.89 | 2022 | |
| Gilead Sciences, INC. | $24.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $22.53 | 2023 | Spravato |
| Horizon Therapeutics Plc | $21.04 | 2022 | |
| Amgen INC. | $20.30 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.08 | 2022 | |
| Sunovion Pharmaceuticals INC. | $19.62 | 2022 | |
| Boston Scientific Corporation | $18.98 | 2022 | |
| Abbott Laboratories | $18.63 | 2022 | |
| Esperion Therapeutics, INC. | $18.18 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lucid Diagnostics INC. | $15.79 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.20 | 2022 | |
| Glaxosmithkline, LLC. | $14.14 | 2022 | |
| Idorsia Pharmaceuticals US INC | $12.95 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Coleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.